Trial Profile
A Phase II Multicentre Multinational Prospective Randomised Double-blind Placebo-controlled Study Assessing the Efficacy and Safety of a Single Application of Three Doses of Dysport in Patients With Upper Back Myofascial Pain Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Back pain; Myofascial pain
- Focus Therapeutic Use
- Sponsors Ipsen
- 12 Jan 2007 Status change
- 16 Nov 2005 New trial record.